{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T21:52:11Z","timestamp":1767649931748,"version":"3.40.5"},"reference-count":53,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"28","license":[{"start":{"date-parts":[[2023,7,14]],"date-time":"2023-07-14T00:00:00Z","timestamp":1689292800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,7,14]]},"abstract":"<jats:sec>\n            <jats:title>Background:<\/jats:title>\n            <jats:p>This research synthesized scientific evidence on the use of pharmacotherapy as intervention to reduce cognitive impairments in adult patients with primary central nervous system (CNS) infections.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>We searched for experimental studies published in English prior to October 2021 in MEDLINE, Embase and Cochrane databases. We included non-randomized studies (NRS) and randomized control trials (RCT) of pharmacotherapy versus placebo, drug, or a combination of drugs in adults with primary CNS infection. The certainty of the evidence was rated according to GRADE guidelines.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>We included 8 RCTs and 1 NRS, involving a total of 805 patients (50.77% male patients; mean age 42.67\u2009\u00b1\u200910.58) with Lyme disease (LD), herpes simplex virus type 1 (HSV-1), or Creutzfeldt\u2013Jakob disease (CJD) studying the efficacy of antibiotics, antiviral, and non-opioid analgesic drugs, respectively. In patients with LD, antibiotics alone or in combination with other drugs enhanced certain cognitive domains relative to placebo. In patients with HSV-1, the results were inconsistent. In patients with CJD, flupirtine maleate enhanced baseline cognitive scores. The quality of RCT studies was low, and the quality of NRS of intervention was very low, suggesting low and very low certainty in the reported results.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>There is limited evidence and low certainty regarding the efficacy of antimicrobials and analgesics in reducing cognitive impairments in patients with LD, HSV-1, and CJD. Future efforts must be aimed at enhancing attention to clinical trial methodology and reporting, as well as reaching a consensus on outcome measures and the endpoint of clinical trials relevant to patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000034151","type":"journal-article","created":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T16:22:57Z","timestamp":1689697377000},"page":"e34151","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Treating cognitive impairments in primary central nervous system infections: A systematic review of pharmacological interventions"],"prefix":"10.1097","volume":"102","author":[{"given":"Syeda T.","family":"Rizvi","sequence":"first","affiliation":[{"name":"University of Toronto, Toronto, ON"},{"name":"KITE Research Institute University Health Network, Toronto, ON"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jhankhana S.","family":"Shah","sequence":"additional","affiliation":[{"name":"University of Toronto, Toronto, ON"},{"name":"KITE Research Institute University Health Network, Toronto, ON"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Shaaya","sequence":"additional","affiliation":[{"name":"University of Toronto, Toronto, ON"},{"name":"KITE Research Institute University Health Network, Toronto, ON"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2787-1848","authenticated-orcid":false,"given":"Tatyana","family":"Mollayeva","sequence":"additional","affiliation":[{"name":"University of Toronto, Toronto, ON"},{"name":"KITE Research Institute University Health Network, Toronto, ON"},{"name":"Trinity College Institute of Neuroscience, Trinity College Dublin, Dublin 2, Ireland."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250504","first-page":"1330","article-title":"Developing a universal vaccine \u2013 technical feasibility and popular perception among microbiologists \u2013 a survey.","volume":"7","author":"Lakshmanan","year":"2020","journal-title":"Eur J Mol Clin Med"},{"key":"R2-20250504","first-page":"68","article-title":"Pathogenesis and classification of central nervous system infection.","volume":"15","author":"Pokorn","year":"2004","journal-title":"EJIFCC"},{"key":"R4-20250504","doi-asserted-by":"crossref","first-page":"e0124005","DOI":"10.1371\/journal.pone.0124005","article-title":"The association between infections and general cognitive ability in young men \u2013 a nationwide study.","volume":"10","author":"Benros","year":"2015","journal-title":"PLoS One"},{"key":"R5-20250504","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bbi.2020.04.072","article-title":"Infections of the central nervous system as a risk factor for mental disorders and cognitive impairment: a nationwide register-based study.","volume":"88","author":"Pedersen","year":"2020","journal-title":"Brain Behav Immun"},{"key":"R9-20250504","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/JNN.0b013e3182527690","article-title":"The impact of inflammation on cognitive function in older adults: implications for healthcare practice and research.","volume":"44","author":"Sartori","year":"2012","journal-title":"J Neurosci Nurs"},{"key":"R10-20250504","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neubiorev.2018.01.001","article-title":"Treatment of PANDAS and PANS: a systematic review.","volume":"86","author":"Sigra","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"issue":"Pt 9","key":"R11-20250504","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1093\/brain\/awl150","article-title":"A systematic review of prion therapeutics in experimental models.","volume":"129","author":"Trevitt","year":"2006","journal-title":"Brain"},{"key":"R12-20250504","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.3390\/ijms20081883","article-title":"Considerations for the use of polyphenols as therapies in neurodegenerative diseases.","volume":"20","author":"Renaud","year":"2019","journal-title":"Int J Mol Sci"},{"key":"R13-20250504","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.3390\/nu10111618","article-title":"The immunomodulatory and anti-inflammatory role of polyphenols.","volume":"10","author":"Yahfoufi","year":"2018","journal-title":"Nutrients"},{"key":"R14-20250504","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3389\/fpubh.2020.00355","article-title":"Clinical use of short-course and low-dose corticosteroids in patients with non-severe COVID-19 during pneumonia progression.","volume":"8","author":"Hu","year":"2020","journal-title":"Front Public Health"},{"key":"R15-20250504","doi-asserted-by":"crossref","first-page":"eaau3333","DOI":"10.1126\/sciadv.aau3333","article-title":"Porphyromonas gingivalis in Alzheimer\u2019s disease brains: evidence for disease causation and treatment with small-molecule inhibitors.","volume":"5","author":"Dominy","year":"2019","journal-title":"Sci Adv"},{"key":"R17-20250504","first-page":"94","article-title":"Repeated antibiotic treatment in chronic lyme disease.","volume":"6","author":"Fallon","year":"1999","journal-title":"J Spirochetal Tick-Borne Dis"},{"key":"R18-20250504","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions.","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"R19-20250504","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials.","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"R20-20250504","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1258\/1355819021927674","article-title":"Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice.","volume":"7","author":"Higgins","year":"2002","journal-title":"J Health Serv Res Policy"},{"key":"R21-20250504","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0895-4356(94)00097-A","article-title":"Best evidence synthesis: an intelligent alternative to meta-analysis.","volume":"48","author":"Slavin","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"R22-20250504","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"R23-20250504","doi-asserted-by":"crossref","first-page":"e1447","DOI":"10.1212\/WNL.0000000000007186","article-title":"Effect of prolonged antibiotic treatment on cognition in patients with Lyme borreliosis.","volume":"92","author":"Berende","year":"2019","journal-title":"Neurology"},{"key":"R24-20250504","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.schres.2017.08.001","article-title":"Emotion discrimination in humans: Its association with HSV-1 infection and its improvement with antiviral treatment.","volume":"193","author":"Bhatia","year":"2018","journal-title":"Schizophr Res"},{"issue":"suppl_1","key":"R25-20250504","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1093\/schbul\/sby014.162","article-title":"39.4 A double-blind trial of valacyclovir to improve cognition in early phase schizophrenia: results from the vista study.","volume":"44","author":"Breier","year":"2018","journal-title":"Schizophr Bull"},{"key":"R26-20250504","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.schres.2018.11.002","article-title":"Herpes simplex virus 1 infection and valacyclovir treatment in schizophrenia: Results from the VISTA study.","volume":"206","author":"Breier","year":"2019","journal-title":"Schizophr Res"},{"key":"R27-20250504","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11011-013-9476-1","article-title":"Predictors of neurocognitive outcomes on antiretroviral therapy after cryptococcal meningitis: a prospective cohort study.","volume":"29","author":"Carlson","year":"2014","journal-title":"Metab Brain Dis"},{"key":"R28-20250504","first-page":"8","article-title":"Neuro-psychological sequelae in HIV-negative cryptococcal meningitis after complete anti-fungal treatment.","volume":"21","author":"Chen","year":"2012","journal-title":"Acta Neurol Taiwanica"},{"key":"R29-20250504","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1212\/01.WNL.0000284604.61160.2d","article-title":"A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy.","volume":"70","author":"Fallon","year":"2008","journal-title":"Neurology"},{"key":"R30-20250504","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.3201\/eid2511.190537","article-title":"Lack of efficacy of high-titered immunoglobulin in patients with west nile virus central nervous system disease.","volume":"25","author":"Gnann","year":"2019","journal-title":"Emerg Infect Dis"},{"key":"R31-20250504","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1212\/01.WNL.0000068030.26992.25","article-title":"Cognitive function in post-treatment Lyme disease Do additional antibiotics help?","volume":"60","author":"Kaplan","year":"2003","journal-title":"Neurology"},{"key":"R32-20250504","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.WNL.0000071227.23769.9E","article-title":"Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial.","volume":"60","author":"Krupp","year":"2003","journal-title":"Neurology"},{"key":"R33-20250504","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s13311-018-0611-x","article-title":"Anti-herpetic medications and reduced risk of dementia in patients with herpes simplex virus infections \u2013 a nationwide, population-based cohort study in Taiwan.","volume":"15","author":"Tzeng","year":"2018","journal-title":"Neurotherapeutics"},{"key":"R34-20250504","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1212\/01.WNL.0000113764.35026.EF","article-title":"Efficacy of flupirtine on cognitive function in patients with CJD: a double-blind study.","volume":"62","author":"Otto","year":"2004","journal-title":"Neurology"},{"key":"R35-20250504","first-page":"151","article-title":"Enterovirus might be involved in Alzheimer\u2019s disease-results from a phase IIa trial evaluating apovir, an antiviral drug combination.","volume":"1","author":"Wahlund","year":"2018","journal-title":"J Prev Alzheimers Dis"},{"key":"R36-20250504","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/schbul\/sbs040","article-title":"Antiherpes virus\u2013specific treatment and cognition in schizophrenia: a test-of-concept randomized double-blind placebo-controlled trial.","volume":"39","author":"Prasad","year":"2013","journal-title":"Schizophr Bull"},{"key":"R37-20250504","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1002\/ana.20944","article-title":"Dexamethasone and long-term outcome in adults with bacterial meningitis.","volume":"60","author":"Weisfelt","year":"2006","journal-title":"Ann Neurol"},{"key":"R38-20250504","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.cmi.2016.07.028","article-title":"N -methyl- d -aspartate receptor autoimmunity affects cognitive performance in herpes simplex encephalitis.","volume":"22","author":"Westman","year":"2016","journal-title":"Clin Microbiol Infect"},{"key":"R39-20250504","doi-asserted-by":"crossref","first-page":"S163","DOI":"10.1016\/j.biopsych.2017.02.417","article-title":"400. Dysfunctional emotion discrimination in schizophrenia is associated with HSV-1 infection and improves with antiviral treatment.","volume":"81","author":"Nimgaonkar","year":"2017","journal-title":"Biol Psychiatry"},{"key":"R40-20250504","first-page":"857","article-title":"Treatment of neurotropic infectious agents to alleviate cognitive deficits in schizophrenia: a test of concept randomized double blind placebo controlled trial.","volume":"35","author":"Prasad","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"R42-20250504","first-page":"72","article-title":"Cognitive processing speed in Lyme disease.","volume":"12","author":"Pollina","year":"1999","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"key":"R43-20250504","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0893-133X(01)00279-2","article-title":"Computerized neurocognitive scanning: II. The profile of schizophrenia.","volume":"25","author":"Gur","year":"2001","journal-title":"Neuropsychopharmacology"},{"key":"R44-20250504","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1176\/appi.ajp.163.3.442","article-title":"Impairment in the specificity of emotion processing in schizophrenia.","volume":"163","author":"Schneider","year":"2006","journal-title":"AJP"},{"key":"R45-20250504","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.schres.2011.10.015","article-title":"The MATRICS consensus cognitive batte3ry (MCCB): clinical and cognitive correlates.","volume":"134","author":"August","year":"2012","journal-title":"Schizophr Res"},{"key":"R46-20250504","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1176\/ajp.141.11.1356","article-title":"A new rating scale for Alzheimer\u2019s disease.","volume":"141","author":"Rosen","year":"1984","journal-title":"AJP"},{"key":"R47-20250504","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"Mini-mental state.","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"R48-20250504","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1002\/1097-4679(198405)40:3<788::AID-JCLP2270400326>3.0.CO;2-T","article-title":"Wechsler adult intelligence scale and wechsler adult intelligence scale-revised in a neurologically impaired population.","volume":"40","author":"Kelly","year":"1984","journal-title":"J Clin Psychol"},{"key":"R49-20250504","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/infdis\/jit616","article-title":"Persistent viral pathogens and cognitive impairment across the life course in the third national health and nutrition examination survey.","volume":"209","author":"Tarter","year":"2014","journal-title":"J Infect Dis"},{"key":"R50-20250504","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41398-022-02044-3","article-title":"Herpes simplex virus 1 infection on grey matter and general intelligence in severe mental illness.","volume":"12","author":"Andreou","year":"2022","journal-title":"Transl Psychiatry"},{"key":"R51-20250504","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.bbi.2020.07.026","article-title":"Purinergic signaling in infectious diseases of the central nervous system.","volume":"89","author":"Alves","year":"2020","journal-title":"Brain Behav Immun"},{"key":"R52-20250504","doi-asserted-by":"crossref","first-page":"40","DOI":"10.2174\/187152911795945123","article-title":"Pathogens and chronic or long-term neurologic disorders.","volume":"11","author":"Starakis","year":"2011","journal-title":"CHDDT"},{"key":"R54-20250504","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.ijbiomac.2021.01.076","article-title":"Trends and strategies to combat viral infections: a review on FDA approved antiviral drugs.","volume":"172","author":"Tompa","year":"2021","journal-title":"Int J Biol Macromol"},{"key":"R55-20250504","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/nrmicro.2016.34","article-title":"Distinguishing between resistance, tolerance and persistence to antibiotic treatment.","volume":"14","author":"Brauner","year":"2016","journal-title":"Nat Rev Microbiol"},{"key":"R56-20250504","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jhin.2018.08.007","article-title":"Balancing the risks to individual and society: a systematic review and synthesis of qualitative research on antibiotic prescribing behaviour in hospitals.","volume":"101","author":"Krockow","year":"2019","journal-title":"J Hosp Infect"},{"key":"R57-20250504","first-page":"59","article-title":"Meta-analysis of sensitivity and specificity of animal studies to detect clinical efficacy of treatments in human trials.","volume":"21","author":"K\u00f6nig","year":"2020","journal-title":"Trials"},{"key":"R58-20250504","first-page":"623","article-title":"Sparse meta-analysis of genome-wide association studies with high-dimensional phenotypes.","volume":"43","author":"Zheng","year":"2019","journal-title":"Genet Epidemiol"},{"key":"R59-20250504","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jclinepi.2015.03.017","article-title":"Small studies are more heterogeneous than large ones: a meta-meta-analysis.","volume":"68","author":"Inthout","year":"2015","journal-title":"J Clin Epidemiol"},{"key":"R60-20250504","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1467-985X.2008.00547.x","article-title":"Bias modelling in evidence synthesis.","volume":"172","author":"Turner","year":"2009","journal-title":"J R Stat Soc Ser A Stat Soc"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034151","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,4]],"date-time":"2025-05-04T01:21:11Z","timestamp":1746321671000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000034151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,14]]},"references-count":53,"journal-issue":{"issue":"28","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000034151","relation":{},"ISSN":["0025-7974"],"issn-type":[{"type":"print","value":"0025-7974"}],"subject":[],"published":{"date-parts":[[2023,7,14]]}}}